Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2,925 | 1 | 72.4% |
| Food and Beverage | $652.10 | 31 | 16.1% |
| Travel and Lodging | $462.51 | 2 | 11.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Microline Surgical Inc | $2,925 | 1 | $0 (2023) |
| Stryker Corporation | $668.29 | 6 | $0 (2024) |
| GlaxoSmithKline, LLC. | $50.87 | 3 | $0 (2023) |
| Amgen Inc. | $50.26 | 4 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $48.77 | 3 | $0 (2024) |
| Medtronic USA, Inc. | $44.41 | 2 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $32.81 | 2 | $0 (2020) |
| Novo Nordisk Inc | $29.55 | 2 | $0 (2021) |
| ABBVIE INC. | $24.73 | 1 | $0 (2022) |
| Abbott Laboratories | $24.48 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $661.37 | 6 | Stryker Corporation ($625.54) |
| 2023 | $3,005 | 6 | Microline Surgical Inc ($2,925) |
| 2022 | $49.21 | 2 | ABBVIE INC. ($24.73) |
| 2021 | $62.05 | 4 | Novo Nordisk Inc ($29.55) |
| 2020 | $55.73 | 4 | Boehringer Ingelheim Pharmaceuticals, Inc. ($15.31) |
| 2019 | $66.09 | 5 | Amgen Inc. ($24.92) |
| 2018 | $71.80 | 4 | Stryker Corporation ($42.75) |
| 2017 | $68.23 | 3 | Medtronic USA, Inc. ($44.41) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/21/2024 | Stryker Corporation | SCOPIS ENT (Device) | Food and Beverage | In-kind items and services | $35.27 | General |
| Category: INSTRUMENTS | ||||||
| 06/15/2024 | Stryker Corporation | SCOPIS ENT (Device) | Travel and Lodging | Cash or cash equivalent | $180.67 | General |
| Category: INSTRUMENTS | ||||||
| 06/13/2024 | Stryker Corporation | XPRESS LOPROFILE (Device) | Food and Beverage | In-kind items and services | $127.76 | General |
| Category: ENTELLUS | ||||||
| 06/04/2024 | Stryker Corporation | SCOPIS ENT (Device) | Travel and Lodging | Cash or cash equivalent | $281.84 | General |
| Category: INSTRUMENTS | ||||||
| 02/27/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/27/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/31/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: RESPIRATORY | ||||||
| 05/25/2023 | Microline Surgical Inc | — | Consulting Fee | Cash or cash equivalent | $2,925.00 | General |
| 04/19/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Diabetes | ||||||
| 01/05/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.27 | General |
| Category: PSYCHIATRY | ||||||
| 10/09/2022 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: Diabetes Care | ||||||
| 09/08/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: NEUROSCIENCE | ||||||
| 08/11/2021 | Olympus America Inc. | CONSOLE, LENS CLEANER InstaClear (Device) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Ear, Nose, Throat | ||||||
| 07/31/2021 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 07/01/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: Diabetes | ||||||
| 03/29/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $11.64 | General |
| Category: Diabetes | ||||||
| 09/10/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: DIABETES | ||||||
| 07/02/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Cardiovascular | ||||||
| 02/19/2020 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: Bone Health | ||||||
| 01/29/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLATRO | Food and Beverage | In-kind items and services | $11.44 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/05/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: RESPIRATORY | ||||||
| 09/23/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: Bone Health | ||||||
| 06/25/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $11.30 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 228 | 265 | $67,282 | $17,178 |
| 2022 | 6 | 233 | 279 | $69,808 | $21,023 |
| 2021 | 5 | 314 | 378 | $111,455 | $34,103 |
| 2020 | 6 | 278 | 371 | $115,424 | $30,259 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 55 | 65 | $12,090 | $4,323 | 35.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 38 | 38 | $11,020 | $2,625 | 23.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 25 | 29 | $9,106 | $2,569 | 28.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $9,768 | $2,550 | 26.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 46 | 58 | $7,134 | $2,469 | 34.6% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2023 | 14 | 17 | $11,390 | $1,337 | 11.7% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 28 | 36 | $6,774 | $1,305 | 19.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 73 | 100 | $18,600 | $6,747 | 36.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 33 | 33 | $14,652 | $4,269 | 29.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 50 | 50 | $14,500 | $4,198 | 29.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 32 | 39 | $12,246 | $3,744 | 30.6% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 33 | 45 | $8,334 | $1,568 | 18.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 12 | 12 | $1,476 | $497.56 | 33.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 98 | 144 | $43,671 | $13,302 | 30.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 93 | 93 | $40,214 | $11,835 | 29.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 72 | 88 | $16,062 | $6,166 | 38.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 20 | 20 | $5,772 | $1,717 | 29.8% |
| 69210 | Removal of impact ear wax, one ear | Office | 2021 | 31 | 33 | $5,736 | $1,083 | 18.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 129 | 212 | $62,053 | $17,131 | 27.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 82 | 82 | $34,130 | $9,491 | 27.8% |
| 69210 | Removal of impact ear wax, one ear | Office | 2020 | 30 | 39 | $6,417 | $1,341 | 20.9% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 13 | 13 | $3,476 | $826.86 | 23.8% |
| 31575 | Diagnostic examination of voice box using flexible endoscope | Office | 2020 | 12 | 12 | $7,110 | $803.48 | 11.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 12 | 13 | $2,238 | $664.79 | 29.7% |
About Dr. Frederick Freeman, MD
Dr. Frederick Freeman, MD is a Otolaryngology healthcare provider based in Hardeeville, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720054646.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Frederick Freeman, MD has received a total of $4,040 in payments from pharmaceutical and medical device companies, with $661.37 received in 2024. These payments were reported across 34 transactions from 18 companies. The most common payment nature is "Consulting Fee" ($2,925).
As a Medicare-enrolled provider, Freeman has provided services to 1,053 Medicare beneficiaries, totaling 1,293 services with total Medicare billing of $102,563. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty Otolaryngology
- Other Specialties Otolaryngology
- Location Hardeeville, SC
- Active Since 02/28/2006
- Last Updated 10/28/2016
- Taxonomy Code 207Y00000X
- Entity Type Individual
- NPI Number 1720054646
Products in Payments
- SCOPIS ENT (Device) $497.78
- XPRESS LOPROFILE (Device) $127.76
- FARXIGA (Drug) $48.77
- FUSION (Device) $44.41
- NAVIGATOR (Device) $42.75
- TRELEGY ELLIPTA (Drug) $34.85
- JARDIANCE (Drug) $32.81
- Ozempic (Drug) $29.55
- EVENITY (Biological) $27.41
- VRAYLAR (Drug) $24.73
- FREESTYLE LIBRE (Device) $24.48
- PROPEL (Device) $23.82
- JANUVIA (Drug) $22.74
- REXULTI (Drug) $18.27
- Xhance (Drug) $17.19
- AREXVY (Drug) $16.02
- CONSOLE, LENS CLEANER InstaClear (Device) $15.31
- Vascepa (Drug) $15.19
- MOUNJARO (Drug) $14.68
- FLEXITOUCH (Device) $13.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.